Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS studyQing Zhou, Yi‐Long Wu, Liyan Jiang et al.|Journal of Cancer Research and Clinical Oncology|2023Cited by 9